Vitrolife AB (publ) (LON:0YAY)
London · Delayed Price · Currency is GBP · Price in SEK 145.76
+9.41 (6.90%)
At close: Oct 17, 2025
Vitrolife AB Market Cap
Vitrolife AB has a market cap or net worth of 1.56 billion as of October 17, 2025. Its market cap has decreased by -37.34% in one year.
Market Cap
1.56B
Enterprise Value
1.65B
Revenue
271.79M
Ranking
n/a
PE Ratio
44.72
Stock Price
145.76
Market Cap Chart
Since June 27, 2001, Vitrolife AB's market cap has increased from 33.54M to 1.56B, an increase of 4,557.01%. That is a compound annual growth rate of 17.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 1.56B | -25.85% |
| Dec 30, 2024 | 2.11B | 2.64% |
| Dec 29, 2023 | 2.05B | 2.23% |
| Dec 30, 2022 | 2.01B | -67.68% |
| Dec 30, 2021 | 6.21B | 195.37% |
| Dec 30, 2020 | 2.10B | 20.08% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 196.07B |
| GSK plc | 65.48B |
| Haleon | 30.42B |
| Smith & Nephew | 11.20B |
| ConvaTec Group | 4.76B |
| Hikma Pharmaceuticals | 3.96B |
| HUTCHMED (China) | 1.97B |
| Genus | 1.80B |